Blockade of alpha-adrenergic receptors by analogues of phosphatidylcholine.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Life Science

• Publication date

  1982-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0024-3205(82)90027-3PMID 6129556
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the alpha 1-adrenergic receptor subtype in a smooth muscle cell line.

  1982cited by this paper
• Alkyl Ether Analogs of Phosphatidylcholine Are Orally Active in Hypertensive Rabbits

  1981cited by this paper
• Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.

  1981cited by this paper
• Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.

  1980cited by this paper
• Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

  1980cited by this paper
• [Release of platelet activating factor (P.A.F.-acether) by isolated perfused rat kidney].

  1980cited by this paper
• Phospholipid methylation and biological signal transmission.

  1980cited by this paper
• Antihypertensive functions of the kidney: Arthur C. Corcoran memorial lecture.

  1980cited by this paper
• Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

  1979cited by this paper
• Arteriolar closure mediated by hyperresponsiveness to norepinephrine in hypertensive rats.

  1979cited by this paper
• Antihypertensive Polar Renomedullary Lipid, A Semisynthetic Vasodilator

  1979cited by this paper
• [Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].

  1979cited by this paper
• Antihypertensive activity of an alkyl ether analog of phosphatidylcholine.

  1979cited by this paper
• Absolute configuration of glycerol derivatives. 7. Enantiomers of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]methyl]-1,4-benzodioxane (WB-4101), a potent competitive alpha-adrenergic antagonist.

  1979cited by this paper
• The coexistence of androgen and glucocorticoid receptors in the DDT1 cloned cell line.

  1977cited by this paper
• Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

  1973cited by this paper
• Membrane-bound enzymes and membrane ultrastructure.

  1973cited by this paper
• The renal medulla as an antihypertensive organ.

  1970cited by this paper
• The renal medulla as an antihypertensive organ.

  1970cited by this paper
• Cytoplasmic granularity of the renal medullary interstitial cells in experimental hypertension.

  1969cited by this paper
• Relationship of cytoplasmic granules in renal papillary interstitial cells to "postsalt" hypertension.

  1969cited by this paper
• Interstitial cell granules in renal papilla and the solute composition of renal tissue in rats with Goldblatt hypertension.

  1969cited by this paper
• Effect of Bilateral Nephrectomy and Kidney Transplantation on Hypertension in Man

  1964cited by this paper
• Development of a strain of spontaneously hypertensive rats.

  1963cited by this paper
• Protection against sodium-overload hypertensive disease. Use of renal tissue and medullorenal extract.

  1962cited by this paper
• Antihypertensive property in renoprival hypertension of extract from renal medulla.

  1960cited by this paper
• Renal autoexplantation and protection against renoprival hypertensive cardiovascular disease and hemolysis.

  1960cited by this paper
• Successful homotransplantation of the human kidney between identical twins.

  1956cited by this paper
• Successful Homotransplantation of the Human Kidney Between Identical Twins

  1956cited by this paper
• Further studies on the mechanism of experimental hypertension in the rat.

  1955cited by this paper
• Further studies on the mechanism of experimental hypertension in the rat.

  1955cited by this paper
• Pathogenesis of renoprival cardiovascular disease in dogs.

  1954cited by this paper
• Papillary necrosis of the kidney; a clinical and experimental correlation.

  1950cited by this paper
• Role of the kidney in pathogenesis of hypertension as determined by a study of the effects of bilateral nephrectomy and other experimental procedures on the blood pressure of the dog.

  1949cited by this paper
• Hypertension after Bilateral Nephrectomy in the Rat

  1947cited by this paper
• The renal origin of hypertension.

  1947cited by this paper

• Identification of Potential Metabolic Markers of Hypertension in Chinese Children

  2021cites this paper
• The pathophysiological effects of Russell's viper (Daboia siamensis) venom and its fractions in the isolated perfused rabbit kidney model: A potential role for platelet activating factor

  2020cites this paper
• New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance.

  1988cites this paper
• Conformational Properties of the PAF-Acether Receptor on Platelets Based on Structure—Activity Studies

  1987cites this paper
• L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.

  1987cites this paper
• Assessment of the Kidney in Relation to Blood Pressure Regulation

  1987cites this paper
• Perspectives in platelet-activating factor research.

  1987cites this paper
• Chemical and biochemical aspects of platelet activating factor: A novel class of acetylated ether‐linked choline‐phospholipids

  1985cites this paper
• Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.

  1985cites this paper
• Biologically active phospholipids as potential cardiovascular drugs

  1984cites this paper
• Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.

  1984cites this paper
• Cardiovascular and renal action of platelet-activating factor in anesthetized dogs.

  1984cites this paper
• Blood pressure and heart rate effects of alkyl ether phospholipids in conscious renal, spontaneously hypertensive, and normotensive rats.

  1983cites this paper